Linda Nebeling
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Linda Nebeling has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Jill Reedy
National Cancer Institute 2 Division of Cancer Control and Population Sciences Rockville, Maryland
2 shared publications - Marissa M. Shams-White
Department of Population Science, American Cancer Society, Atlanta, GA 30303, USA
2 shared publications - Susan M. Czajkowski
Division of Cancer Control and Population Sciences, National Cancer Institute , Rockville, MD 20850, United States
2 shared publications - Audrey Goldbaum
National Cancer Institute 1 Cancer Prevention Fellowship Program, Division of Cancer Prevention Rockville, Maryland
1 shared publication - Caitlin P. Bailey
National Cancer Institute, National Institutes of Health, Bethesda, USA
1 shared publication - Edward R. Sauter
National Cancer Institute 10 Rockville, MD
1 shared publication
Latest Publications
- 2 May 2025
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 85 (9) , 1567
Nathan Berger, MD: In Memoriam (1941–2024)
- 2 May 2025
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 85 (9) , 1567
Nathan Berger, MD: In Memoriam (1941–2024)
- 12 December 2024
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 117 (7) , 1311-1315
Time-restricted eating and cancer: lessons learned and considerations for a path forward
Time-restricted eating is a type of intermittent fasting. Food can be consumed as desired during the eating period but not during the remainder of the day. Studies suggest that many of the health benefits of fasting may not simply be the result of weight loss but also due to the body’s responses to the fasting that leads to improved metabolic functioning. Whereas animal studies are convincing regarding the benefits of time-restricted feeding, human time-restricted eating studies are less consistent and generally short term (<1 year). In 2020, the National Cancer Institute funded 5 intermittent fasting studies, 4 of which focused on time-restricted eating, which addressed the question: How does intermittent fasting affect cancer incidence, treatment response, or outcome? The National Cancer Institute sponsored a webinar in 2023 featuring investigators of the funded studies in which they discussed challenges as well as their thoughts regarding the most important time-restricted eating topics that should be addressed going forward; 6 areas were identified, which are discussed below as well as in a recently published NOT-CA-24-073: Factors Impacting How Time-Restricted Eating (TRE) Influences Cancer-Related Outcomes. Moving the science forward will allow the scientific community to better understand time-restricted eating’s potential. This potential includes the development of targeted time-restricted eating interventions to optimize long-term adherence to the intervention, which is required to better understand its potential benefits in cancer risk and increased response to cancer treatment, as well as improved quality and quantity of life among cancer survivors.
- 12 December 2024
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 117 (7) , 1311-1315
Time-restricted eating and cancer: lessons learned and considerations for a path forward
Time-restricted eating is a type of intermittent fasting. Food can be consumed as desired during the eating period but not during the remainder of the day. Studies suggest that many of the health benefits of fasting may not simply be the result of weight loss but also due to the body’s responses to the fasting that leads to improved metabolic functioning. Whereas animal studies are convincing regarding the benefits of time-restricted feeding, human time-restricted eating studies are less consistent and generally short term (<1 year). In 2020, the National Cancer Institute funded 5 intermittent fasting studies, 4 of which focused on time-restricted eating, which addressed the question: How does intermittent fasting affect cancer incidence, treatment response, or outcome? The National Cancer Institute sponsored a webinar in 2023 featuring investigators of the funded studies in which they discussed challenges as well as their thoughts regarding the most important time-restricted eating topics that should be addressed going forward; 6 areas were identified, which are discussed below as well as in a recently published NOT-CA-24-073: Factors Impacting How Time-Restricted Eating (TRE) Influences Cancer-Related Outcomes. Moving the science forward will allow the scientific community to better understand time-restricted eating’s potential. This potential includes the development of targeted time-restricted eating interventions to optimize long-term adherence to the intervention, which is required to better understand its potential benefits in cancer risk and increased response to cancer treatment, as well as improved quality and quantity of life among cancer survivors.
- 16 December 2023
- Published by Elsevier in Journal of the Academy of Nutrition and Dietetics
- Vol. 124 (8) , 1029-1040
Time-Restricted Eating in Community-Dwelling Adults: Correlates of Adherence and Discontinuation in a Cross-Sectional Online Survey Study
- 16 December 2023
- Published by Elsevier in Journal of the Academy of Nutrition and Dietetics
- Vol. 124 (8) , 1029-1040
Time-Restricted Eating in Community-Dwelling Adults: Correlates of Adherence and Discontinuation in a Cross-Sectional Online Survey Study